12 February 2019

While The NHS Drags Its Heels On PrEP, This Is How Men Are Being Affected

Although NHS England increased places in the PrEP Impact Trial to 13,000 participants in summer and recently said it hopes to extend this to 26,000 before 2020, it is yet to confirm when these places will become available – or what will happen when the three-year trial is up. Around 40% of trial clinics across England are currently turning away gay and bisexual men due to oversubscription, according to the Terrence Higgins Trust. Six men who’ve failed to access PrEP have told HuffPost UK the experience has left them feeling “depressed”, “anxious” and “frustrated”.
12 February 2019

A Trailblazing HIV Doctor Who Helped Thousands Access PrEP Has Died At Age 44

Dr Mags Portman, a hero of the LGBT and HIV community, leaves behind a husband, two children, and a legacy: getting PrEP into the hands of those who need it.
12 February 2019

Correlation between HIV, rectal gonorrhea could help PrEP trial designs

Rectal gonorrhea incidence may serve to estimate what HIV incidence would have been had trial participants not received PrEP, according to study findings.
11 February 2019

To Halt HIV, Advocates Push For PrEP Outreach To Black Women

In 2013, not quite a year after the Food and Drug Administration approved the drug Truvada for HIV prevention, a coalition of 50 experts in HIV and women's health called on U.S. public health agencies to promote the pill and its approach, called pre-exposure prophylaxis, or PrEP, explicitly to women. Not much happened.
7 February 2019

Trump's HIV pledge comes as Gilead pumps cash into Truvada for PrEP

Gilead is looking to eventually sub out Truvada for its newer HIV drug Descovy when it comes to pre-exposure prophylaxis. But in the meantime, it’s socking cash into promoting the older brand for PrEP.
4 February 2019

What's Going On with the NHS PrEP Trial in England?

NHS Engalnd delayed plans to fund doubling the trial in size, just days after its announcement – and that may leave people at even greater risk.
30 January 2019

“Nothing feels better than being confident that you are healthy” – a young man’s experience of PrEP

PrEP recently became available in Ukraine, and for Georgii Onyschuk, a 29-year-old marketing professional from Kyiv, it has become a normal part of life as a young gay man.
25 January 2019

For the greatest impact, end caps on PrEP access now

NHS England continues to limit the roll-out of PrEP. Waiting until the Impact trial completes is reckless—for the greatest impact, make PrEP available now to all who need it.
25 January 2019

PrEP promotion should be positive and inclusive

Pre-exposure prophylaxis (PrEP) programmes should adopt modern marketing strategies that are attractive to healthy individuals and that might promote an inclusive and holistic vision of PrEP, Dr K Rivet Amico and Professor Linda-Gail Bekker argue in an opinion piece published in The Lancet HIV. They note that the roll-out of PrEP has lagged
25 January 2019

How did Kenya build Africa’s largest PrEP programme?

Around 25,000 people are taking pre-exposure prophylaxis (PrEP) in Kenya, making it Africa’s largest PrEP programme, ahead of South Africa (9000 people), Uganda (4000) and Zimbabwe (4000). The roll-out was recently described by officials from Kenya’s Ministry of Health in the journal Sexual Health and also at October's HIV Research for Prevention conference. Overall 5.6%
23 January 2019

HIV prevention gridlock as proposed extra NHS PrEP delayed

A proposal to double the number of people able to access PrEP (a highly effective HIV prevention pill) through the PrEP Impact Trial has been delayed by the trial oversight board. This is despite the fact that NHS England has agreed to fund the additional 13,000 places. Currently, many clinics have no spaces for additional patients and are turning away people at high risk of HIV, some of whom are going on to acquire the virus.
23 January 2019

PrEP IMPACT trial update – January 2019

The PrEP Oversight Board met on 15th January 2019. The main item for discussion was a recommendation from the research team to increase trial places... Before final approval is given, the Board asked that rapid engagement with local authority commissioners and research sites be undertaken to assess their capacity to accept additional places... The Board will meet again within the next few weeks once these actions are complete, to confirm final decisions on increasing capacity, after which point additional places could then be allocated to participating clinics.
11 January 2019

Meta-analysis finds high but variable STI rates in PrEP studies – is PrEP the cause or a potential solution?

A new meta-analysis of 20 studies and roll-out projects of HIV pre-exposure prophylaxis (PrEP) in gay and bisexual men confirms very high rates of diagnosis of sexually transmitted infections (STIs) in study participants and PrEP takers. Dr Ricardo Werner and colleagues from the Berlin Institute of Health analyse STI rates in the largest dataset
8 January 2019

Growth in positive attitudes towards PrEP among Australian gay and bisexual men

Willingness to consider using pre-exposure prophylaxis (PrEP) increased between 2011 and 2017 among gay and bisexual men in Australia, while concerns about using it decreased, according to research published in AIDS and Behavior. Community support for PrEP users remained solid.“We found that attitudes towards PrEP among Australian GBM [gay and bisexual men] have become more
7 January 2019

Six innovative models for PrEP services

For pre-exposure prophylaxis (PrEP) to have a substantial public health impact, access to PrEP needs to be improved so that more people who would benefit from it receive PrEP. Services need to adapt and innovate. A series of recent articles, most of them published in a special issue of Sexual Health, outline a range
20 December 2018

HIV infections among black gay men taking PrEP, probably due to poor adherence

Awareness and use of HIV pre-exposure prophylaxis (PrEP) among black gay, bisexual and other men who have sex with men (MSM) in the United States increased significantly between 2014 and 2017, according to research published in the 1 November edition of the Journal of Acquired Immune Deficiency Syndromes. The study also showed that
29 November 2018

HIV diagnoses fell in the UK in 2017 for the first time among all risk groups, all ethnicities and in all regions, annual report reveals

The 2018 report from Public Health England is entitled Progress towards ending the HIV epidemic in the United Kingdom, and for once the note of optimism in the title is justified.The report describes an epidemic in which new diagnoses fell in gay men, heterosexuals and all other groups; in people born in
26 November 2018

High levels of unmet PrEP needs among transgender women in Brazil

A study recently published in The Journal of Acquired Immune Deficiency Syndromes indicates that transgender (trans) women in Brazil had low levels of pre-exposure prophylaxis (PrEP) awareness. This was combined with significant proportions being willing to use PrEP as a prevention tool and being eligible for PrEP.Another recent qualitative study published in Culture, Health and Sexuality
15 November 2018

Removable PrEP implant produces high drug levels in rabbits; further studies planned

A small removable plastic implant resembling a tiny piece of dry spaghetti is capable of delivering sustained levels of the drug tenofovir, researchers told last month’s HIV Research for Prevention conference (HIVR4P 2018) in Madrid.The drug delivery capability of the implants was tested on rabbits and will now advance into tests on dogs
13 November 2018

PROUD qualitative findings: PrEP’s impact on sexual behaviour

Qualitative data from the PROUD study revealed that pre-exposure prophylaxis (PrEP) is an important added prevention tool to strategies already in place for men in England having frequent condomless sex, according to a recent article in AIDS and Behavior. While approximately half of the participants indicated that they had made changes to other risk reduction strategies